tiprankstipranks
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market

Dogwood Therapeutics (DWTX) Financial Statements

Compare
185 Followers

Dogwood Therapeutics Financial Overview

Dogwood Therapeutics's market cap is currently $6.38M. The company's EPS TTM is $-6.308; its P/E ratio is ―; Dogwood Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -5.45M$ -12.32M$ -15.64M$ -10.01M$ -2.18M
EBITDA$ -5.45M$ -12.32M$ -15.97M$ -10.01M$ -2.18M
Net Income$ -5.30M$ -12.25M$ -15.96M$ -10.35M$ -2.47M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 4.17M$ 8.37M$ 15.78M$ 31.47M$ 315.90K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 3.64M
Net Debt$ -3.32M$ -7.03M$ -14.01M$ -29.80M$ 3.33M
Total Liabilities$ 358.55K$ 1.04M$ 1.28M$ 1.53M$ 5.26M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -4.87M$ -11.47M$ -15.69M$ -3.90M$ -2.09M
Operating Cash Flow$ -4.87M$ -11.47M$ -15.69M$ -3.90M$ -2.09M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

Dogwood Therapeutics Debt to Assets

Dogwood Therapeutics Cash Flow

Dogwood Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis